Wednesday, July 22, 2026

Unlocking the Future: LS Electric’s Innovative DC Power Solutions at DISTRIBUTECH 2026

LS Electric will showcase innovative power solutions at DISTRIBUTECH 2026, targeting the North American market with DC technologies.

K-Medical Tourism Targets Visitors from Russia and Central Asia Who Spend 40% More than Average

South Korea's medical tourism exceeds 2 million visitors, targeting high-spending tourists from Russia and Central Asia through promotional campaigns.

The Day Manila Fell: How Japan’s 1942 Occupation Shaped the Pacific War

The Japanese occupation of Manila in 1942 marked a pivotal moment in the Pacific War, leading to suffering and resistance among Filipinos.

Tag: IND approval

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us